NCT06620627招募中不适用
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (PROCEED-CRC)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Natera, Inc.
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Primary Objective
研究概览
简要总结
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
详细描述
Participants who meet study inclusion criteria will be invited to enroll in the study and will provide written consent prior to study procedures. Participants will provide blood samples and will be required to have a colonoscopy performed within 120 days of their blood draw. No test results from the blood collection will be provided to participants or clinicians.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •40 years of age or older at time of consent.
- •Planning or intending to undergo asymptomatic screening colonoscopy.
- •Able to tolerate venipuncture for research draw(s).
- •Able and willing to provide blood samples within the 120 days prior to a colonoscopy procedure.
- •Willing and able to comply with the study visit schedule and study requirements.
- •Signed informed consent(s) must be obtained prior to participation in the study
排除标准
- •Any prior history of any kind of malignancy (exception: participants who have undergone surgical removal of skin squamous cell or basal cell cancer may be enrolled provided the procedure was completed at least 12 months prior to the date of provision of informed consent for the study)
- •Had a complete colonoscopy with adequate bowel preparation in the previous nine (9) years.
- •Undergoing diagnostic colonoscopy for investigation of symptoms such as unexplained and long-lasting diarrhea, overt rectal bleeding, e.g., hematochezia or melena, within the previous 30 days. (Blood on toilet paper, after wiping, does not constitute rectal bleeding)
- •Undergone colorectal cancer screening within the associated recommended intervals
- •FOBT/FIT within the previous 12 months
- •FIT-DNA test within the previous 36 months
- •Blood-based CRC screening test within the previous 36 months
- •Computed tomography colonography CTC within the previous 5 years
- •Flexible sigmoidoscopy within the previous 5 years
- •Precancerous findings on most recent colonoscopy. This does not include benign, and/or hyperplastic polyps of any size (Note: Tissue biopsies that result in no histopathology findings are acceptable)
- •Had a prior colorectal resection for any reason other than sigmoid diverticular disease
- •Diagnosis or personal history of any of the following high-risk conditions for colorectal cancer:
- •Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohns disease
- •Familial adenomatous polyposis (also referred to as FAP, including attenuated FAP)
- •Hereditary non-polyposis colorectal cancer syndrome (also referred to as HNPCC or Lynch Syndrome)
- •Other hereditary cancer syndromes including but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Gardners Syndrome, Turcots (or Crails) Syndrome, Cowdens Syndrome, Juvenile Polyposis, Cronkhite-Canada Syndrome, Neurofibromatosis and Familial Hyperplastic Polyposis
结局指标
主要结局
Primary Objective
时间窗: 12 months
To collect samples for the research use and the development of a blood-based colorectal cancer screening test in the average risk population
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A Clinicobiological Database in Metastatic Digestive CancersDigestive System NeoplasmNCT03978078Institut du Cancer de Montpellier - Val d'Aurelle200
招募中
不适用
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental ResearchNon Small Cell Lung CancerNCT05669105Sanguine Biosciences200
已完成
不适用
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular MarkersPreeclampsiaNCT02808494Illumina, Inc.242
已完成
不适用
Study Vitamin D in Healthy IndividualsVitamin D DeficiencyNCT02250625Fujirebio Diagnostics, Inc.482
招募中
不适用
Immune Reconstitution in Stem Cell Transplant RecipientsCancerNCT02129543University of Miami700